You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Medunik Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MEDUNIK, and what generic and branded alternatives to MEDUNIK drugs are available?

MEDUNIK has two approved drugs.

Summary for Medunik

US Patents:	0
Tradenames:	2
Ingredients:	2
NDAs:	2

Drugs and US Patents for Medunik

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Medunik	NITISINONE	nitisinone	CAPSULE;ORAL	212390-004	Apr 27, 2023	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Medunik	NITISINONE	nitisinone	CAPSULE;ORAL	212390-002	May 26, 2022	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Medunik	NITISINONE	nitisinone	CAPSULE;ORAL	212390-003	May 26, 2022	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Medunik	NITISINONE	nitisinone	CAPSULE;ORAL	212390-001	May 26, 2022	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Medunik	PHEBURANE	sodium phenylbutyrate	PELLETS;ORAL	216513-001	Jun 17, 2022		RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Medunik

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.